Article Text

Rare disease
Extracorporeal membrane oxygenation (ECMO) for severe acute respiratory distress syndrome (ARDS) in fulminant blastomycosis in Germany
  1. Markus Resch1,
  2. Katrin Kurz2,
  3. Wulf Schneider-Brachert3,
  4. Kathrin Tintelnot4,
  5. Christoph Birner1,
  6. Thomas Schichtl1,
  7. Matthias Lubnow1,
  8. Christina Hart5,
  9. Clemens Jilek1,
  10. Simone Bertz2,
  11. Michael Hilker6,
  12. Günter A J Riegger1,
  13. Andreas Luchner1,
  14. Thomas Müller1
  1. 1
    Regensburg University Medical Center, Department of Internal Medicine II, Franz-Josef-Strauss-Allee 11, Regensburg, 93053, Germany
  2. 2
    Regensburg University Medical Center, Department of Pathology, Franz-Josef-Strauss-Allee 11, Regensburg, 93053, Germany
  3. 3
    Regensburg University Medical Center, Department of Microbiology, Franz-Josef-Strauss-Allee 11, Regensburg, 93053, Germany
  4. 4
    Robert Koch-Institut, Nordufer 20, Berlin, 13353, Germany
  5. 5
    Regensburg University Medical Center, Department of Internal Medicine I, Franz-Josef-Strauss-Allee 11, Regensburg, 93053, Germany
  6. 6
    Regensburg University Medical Center, Department of Cardiac and Thoracic Surgery, Franz-Josef-Strauss-Allee 11, Regensburg, 93053, Germany
  1. Markus Resch, Markus.Resch{at}klinik.uni-regensburg.de

Summary

In fulminant blastomycosis with multiorgan failure, the earliest diagnosis possible is crucial for successful treatment. If severe acute respiratory distress syndrome (ARDS) develops, miniaturised veno-venous extracorporeal membrane oxygenation (ECMO) might provide a unique and efficacious possibility to prolong the time frame for diagnosis and the beginning of treatment. This is the first report on a case of fatal blastomycosis in Germany. It reminds us to add exotic infections to the differential diagnosis in patients with refractory pneumonia in the era of worldwide tourism.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Markus Resch and Kratin Kurz contributed equally to this case report

  • Competing interests: none.

  • Patient consent: Patient/guardian consent was obtained for publication

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.